Tool for risk assessment of nanomaterials in cosmetics Both regulators and manufacturers need to evaluate and manage consumer health risks that may be posed by the use of nanomaterials in cosmetics.
New possibilities for the responsible recycling of plastics RIVM proposes the consideration of a broader environmental perspective in the trade-off between incineration or recycling of plastics.
Priorities for science and society about the influence of ecosystems on well-being An international network of researchers has set new priorities for science and society in the area of ecosystems and their influence on social well-being.
Standards for three drugs in Dutch surface water RIVM proposes water quality standards for three drugs in surface water: carbamazepine (epilepsy), metoprolol (heart disease) and metformin (diabetes).
Safety of the nanomaterial SAS (silica) in food still uncertain Uncertainty still remains over the safety of the nanomaterial SAS in food. Food additive E551 consists of ‘synthetic amorphous silica’ (SAS) and is applied as an anti-caking agent.
Open and sustainable building for RIVM and MEB The Central Government Real Estate Agency has awarded the contract to build new premises for two knowledge institutes - RIVM and the MEB - to StruktonHurks.
No new MERS patients in the Netherlands Almost two months ago, two Dutch people were diagnosed with the MERS coronavirus.
Declaration PAN Europe regarding RIVM Statement of PAN Europe regarding the contents of her report ‘A Poisonous Injection’ June 26, 2014.
Average participation in the National Immunisation Programme in the Netherlands around 95% From the RIVM report 'Vaccination level of the National Immunisation Programme of the Netherlands' (report year 2014) the strong commitment of Community Health Services (GGD’s) and child welfare ce
Examine patients with acute Q fever again after a year If patients with acute Q fever are re-examined for antibodies one year after their infection, 98% of the patients with chronic Q fever can be detected.